{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:45:47Z","timestamp":1776735947336,"version":"3.51.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rash and cholestatic liver injury caused by methimazole (MMI) in patients with Turner syndrome (TS) and Graves\u2019s disease (GD) are rarely reported, and there is a paucity of reports on the management of this condition. It is not clear whether propylthiouracil (PTU) can be used as a safe alternative in this case.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation:<\/jats:title>\n                <jats:p>A 37-year-old woman was admitted to our hospital with rash, severe pruritus and a change in urine colour after 2 months of GD treatment with MMI. Physical examination showed rash scattered over the limbs and torso, mild jaundice of the sclera and skin, short stature, facial moles, immature external genitals and diffuse thyroid gland enlargement. Liver function tests indicated an increase in total bilirubin, direct bilirubin, total bile acid, glutamic pyruvic transaminase, glutamic oxaloacetic transaminase and alkaline phosphatase. The level of sex hormones suggested female hypergonadotropic hypogonadism. The karyotype of peripheral blood was 46, X, i(X)(q10)\/45, X. After excluding biliary obstruction and other common causes of liver injury, combined with rash and abnormal liver function following oral administration of MMI, the patient was diagnosed as having TS with GD and rash and cholestatic liver injury caused by MMI. MMI was immediately discontinued, and eleven days after treatment with antihistamine and hepatoprotective agents was initiated, the rash subsided, and liver function returned to nearly normal. Because the patient did not consent to administration of <jats:sup>131<\/jats:sup>I or thyroid surgery, hyperthyroidism was successfully controlled with PTU. No adverse drug reactions were observed after switching to PTU.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>While patients with TS and GD are undergoing treatment with MMI, their clinical manifestations, liver functions, and other routine blood test results should be closely monitored. When patients with TS and GD manifest adverse reactions to MMI such as rash and cholestatic liver injury, it is necessary to discontinue MMI and treat with antihistamine and hepatoprotective agents. After the rash subsides and liver function returns to nearly normal, PTU can effectively control hyperthyroidism without adverse drug reactions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-021-00819-1","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T12:30:58Z","timestamp":1630672258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves\u2019s disease: a case report and literature review"],"prefix":"10.1186","volume":"21","author":[{"given":"Jinhui","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangtao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"issue":"10","key":"819_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41574-019-0224-4","volume":"15","author":"CH Gravholt","year":"2019","unstructured":"Gravholt CH, Viuff MH, Brun S, Stochholm K, Andersen NH. Turner syndrome: mechanisms and management. Nat Rev Endocrinol. 2019;15(10):601\u201314.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"819_CR2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0430","volume":"177","author":"CH Gravholt","year":"2017","unstructured":"Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA, Rubin K, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177(3):G1-g70.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"819_CR3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.27270","volume":"62","author":"KT J\u00f8rgensen","year":"2010","unstructured":"J\u00f8rgensen KT, Rostgaard K, Bache I, Biggar RJ, Nielsen NM, Tommerup N, Frisch M. Autoimmune diseases in women with Turner\u2019s syndrome. Arthritis Rheum. 2010;62(3):658\u201366.","journal-title":"Arthritis Rheum"},{"key":"819_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fendo.2019.00511","volume":"10","author":"M Wegiel","year":"2019","unstructured":"Wegiel M, Antosz A, Gieburowska J, Szeliga K, Hankus M, Grzybowska-Chlebowczyk U, Wiecek S, Malecka-Tendera E, Gawlik A. Autoimmunity Predisposition in Girls With Turner Syndrome. Front Endocrinol (Lausanne). 2019;10:511.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"819_CR5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1089\/thy.2005.15.1061","volume":"15","author":"S Livadas","year":"2005","unstructured":"Livadas S, Xekouki P, Fouka F, Kanaka-Gantenbein C, Kaloumenou I, Mavrou A, Constantinidou N, Dacou-Voutetakis C. Prevalence of thyroid dysfunction in Turner\u2019s syndrome: a long-term follow-up study and brief literature review. Thyroid. 2005;15(9):1061\u20136.","journal-title":"Thyroid"},{"issue":"1","key":"819_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13052-018-0447-3","volume":"44","author":"T Aversa","year":"2018","unstructured":"Aversa T, Gallizzi R, Salzano G, Zirilli G, De Luca F, Valenzise M. Atypical phenotypic aspects of autoimmune thyroid disorders in young patients with Turner syndrome. Ital J Pediatr. 2018;44(1):12.","journal-title":"Ital J Pediatr"},{"issue":"4","key":"819_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000357130","volume":"81","author":"M Valenzise","year":"2014","unstructured":"Valenzise M, Aversa T, Corrias A, Mazzanti L, Cappa M, Ubertini G, Scarano E, Mussa A, Messina MF, De Luca F, et al. Epidemiology, presentation and long-term evolution of Graves\u2019 disease in children, adolescents and young adults with Turner syndrome. Horm Res Paediatr. 2014;81(4):245\u201350.","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"819_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2249.2009.03895.x","volume":"156","author":"KH Mortensen","year":"2009","unstructured":"Mortensen KH, Cleemann L, Hjerrild BE, Nexo E, Locht H, Jeppesen EM, Gravholt CH. Increased prevalence of autoimmunity in Turner syndrome\u2013influence of age. Clin Exp Immunol. 2009;156(2):205\u201310.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"819_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1515\/jpem-2019-0067","volume":"32","author":"J Stoklasova","year":"2019","unstructured":"Stoklasova J, Zapletalova J, Frysak Z, Hana V, Cap J, Pavlikova M, Soucek O, Lebl J. An isolated Xp deletion is linked to autoimmune diseases in Turner syndrome. J Pediatr Endocrinol Metab. 2019;32(5):479\u201388.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"819_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1507\/endocrj.EJ17-0401","volume":"65","author":"K Hanew","year":"2018","unstructured":"Hanew K, Tanaka T, Horikawa R, Hasegawa T, Yokoya S. Prevalence of diverse complications and its association with karyotypes in Japanese adult women with Turner syndrome\u2014a questionnaire survey by the Foundation for Growth Science\u2014. Endocr J. 2018;65(5):509\u201319.","journal-title":"Endocr J"},{"issue":"1","key":"819_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4274\/jcrpe.1771","volume":"7","author":"E Ye\u015filkaya","year":"2015","unstructured":"Ye\u015filkaya E, Bereket A, Darendeliler F, Ba\u015f F, Poyrazo\u011flu \u015e, K\u00fc\u00e7\u00fckemre Ayd\u0131n B, Darcan \u015e, D\u00fcndar B, B\u00fcy\u00fckinan M, Kara C, et al. Turner syndrome and associated problems in Turkish children: a multicenter study. J Clin Res Pediatr Endocrinol. 2015;7(1):27\u201336.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"6","key":"819_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1530\/EJE-18-0878","volume":"180","author":"E Fiot","year":"2019","unstructured":"Fiot E, Z\u00e9naty D, Boizeau P, Haignere J, Dos Santos S, L\u00e9ger J. X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood. Eur J Endocrinol. 2019;180(6):397\u2013406.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"819_CR13","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1089\/thy.2013.0452","volume":"24","author":"T Aversa","year":"2014","unstructured":"Aversa T, Lombardo F, Corrias A, Salerno M, De Luca F, Wasniewska M. In young patients with Turner or Down syndrome, Graves\u2019 disease presentation is often preceded by Hashimoto\u2019s thyroiditis. Thyroid. 2014;24(4):744\u20137.","journal-title":"Thyroid"},{"issue":"11","key":"819_CR14","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s40618-019-01054-1","volume":"42","author":"F Azizi","year":"2019","unstructured":"Azizi F, Malboosbaf R. Safety of long-term antithyroid drug treatment? A systematic review. J Endocrinol Invest. 2019;42(11):1273\u201383.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"819_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4158\/EP-2019-0221","volume":"26","author":"W Yu","year":"2020","unstructured":"Yu W, Wu N, Li L, Wang J, OuYang H, Shen H. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS. Endocr Pract. 2020;26(2):207\u201317.","journal-title":"Endocr Pract"},{"issue":"10","key":"819_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1517\/14740338.2014.953796","volume":"13","author":"A Akmal","year":"2014","unstructured":"Akmal A, Kung J. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity. Expert Opin Drug Saf. 2014;13(10):1397\u2013406.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"819_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1089\/thy.2014.0350","volume":"25","author":"J Yang","year":"2015","unstructured":"Yang J, Li LF, Xu Q, Zhang J, Weng WW, Zhu YJ, Dong MJ. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China. Thyroid. 2015;25(3):278\u201383.","journal-title":"Thyroid"},{"issue":"10","key":"819_CR18","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343\u2013421.","journal-title":"Thyroid"},{"issue":"2","key":"819_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1365-2265.2012.04365.x","volume":"77","author":"F Otsuka","year":"2012","unstructured":"Otsuka F, Noh JY, Chino T, Shimizu T, Mukasa K, Ito K, Ito K, Taniyama M. Hepatotoxicity and cutaneous reactions after antithyroid drug administration. Clin Endocrinol (Oxf). 2012;77(2):310\u20135.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"819_CR20","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.18632\/oncotarget.6144","volume":"7","author":"H Zou","year":"2016","unstructured":"Zou H, Jin L, Wang LR, Braddock M, Cai WW, Zheng MH. Methimazole-induced cholestatic hepatitis: two cases report and literature review. Oncotarget. 2016;7(4):5088\u201391.","journal-title":"Oncotarget"},{"issue":"6","key":"819_CR21","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","volume":"70","author":"EASL Clinical","year":"2019","unstructured":"EASL Clinical. Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70(6):1222\u201361.","journal-title":"J Hepatol"},{"issue":"4","key":"819_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/BF03349383","volume":"3","author":"C Marcocci","year":"1980","unstructured":"Marcocci C, Bartalena L, Martino E, Fenzi GF, Pinchera A. Graves\u2019 disease and Turner\u2019s syndrome. J Endocrinol Invest. 1980;3(4):429\u201331.","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"819_CR23","doi-asserted-by":"publisher","first-page":"e19518","DOI":"10.1097\/MD.0000000000019518","volume":"99","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhang X, Yang M. Clinical case report: A case of Turner syndrome with Graves\u2019 disease. Medicine. 2020;99(11):e19518.","journal-title":"Medicine"},{"issue":"21","key":"819_CR24","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1001\/jama.1981.03320210011004","volume":"246","author":"T Hirano","year":"1981","unstructured":"Hirano T. Association of Graves\u2019 Disease With Turner\u2019s Syndrome. JAMA. 1981;246(21):2429\u20139.","journal-title":"JAMA"},{"issue":"1","key":"819_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.pec.0000195763.42941.9f","volume":"22","author":"OT Hardy","year":"2006","unstructured":"Hardy OT, Smolinski KN, Yan AC, Grimberg A. PTU-associated vasculitis in a girl with Turner Syndrome and Graves\u2019 disease. Pediatr Emerg Care. 2006;22(1):52\u20134.","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"819_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/20009666.2017.1422673","volume":"8","author":"A Trusau","year":"2018","unstructured":"Trusau A, Brit ML. Propylthiouracil-induced ANCA-negative cutaneous small vessel vasculitis. J Community Hosp Intern Med Perspect. 2018;8(1):35\u20137.","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"819_CR27","doi-asserted-by":"publisher","first-page":"109095","DOI":"10.1016\/j.biopha.2019.109095","volume":"117","author":"X Li","year":"2019","unstructured":"Li X, Jin S, Fan Y, Fan X, Tang Z, Cai W, Yang J, Xiang X. Association of HLA-C*03:02 with methimazole-induced liver injury in Graves\u2019 disease patients. Biomed Pharmacother. 2019;117:109095.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"819_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jid.2020.05.117","volume":"141","author":"H Xiong","year":"2021","unstructured":"Xiong H, Jiang M, Shao F, Ye H, Zhang W, Chen Z, Zeng F, Chen SA, Yuan H, Yan L, et al. Risk and Association of HLA Alleles with Methimazole-Induced Cutaneous Adverse Reactions in Chinese Han Population. J Invest Dermatol. 2021;141(2):437\u201340.","journal-title":"J Invest Dermatol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00819-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-021-00819-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00819-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T12:31:22Z","timestamp":1630672282000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-021-00819-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/s12902-021-00819-1","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"20 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the Declaration of Helsinki and was approved by the Institutional Ethics Committee of The Second Affiliated Hospital of Xiamen Medical College. (Xiamen, China). Written informed consents were obtained from all the study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}